|Articles|June 10, 2016
Oral Dose Development for Macromolecules
Author(s)Catalent Pharma Solutions
#wpbut {border: 3px solid #245998; border-radius:40px; border-color: #245998; padding: 15px 30px; font-size:15px !important;} #wpbut:hover {background: #15355a; color: #fff !important; transition: .5s;}
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
How ten23 health is Advancing Patient-Centric Drug Delivery
2
FDA, Duke University Planning Epinephrine Access Workshop for December
3
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
4
PharmTech Weekly News Roundup — Week of November 24, 2025
5
